Nothing Special   »   [go: up one dir, main page]

Skip to main content

Imaging Signature of 1p/19q Co-deletion Status Derived via Machine Learning in Lower Grade Glioma

  • Conference paper
  • First Online:
Radiomics and Radiogenomics in Neuro-oncology (RNO-AI 2019)

Part of the book series: Lecture Notes in Computer Science ((LNIP,volume 11991))

Abstract

We present a new approach to quantify the co-deletion of chromosomal arms 1p/19q status in lower grade glioma (LGG). Though the surgical biopsy followed by fluorescence in-situ hybridization test is the gold standard currently to identify mutational status for diagnosis and treatment planning, there are several imaging studies to predict the same. Our study aims to determine the 1p/19q mutational status of LGG non-invasively by advanced pattern analysis using multi-parametric MRI. The publicly available dataset at TCIA was used. T1-W and T2-W MRIs of a total 159 patients with grade-II and grade-III glioma, who had biopsy proven 1p/19q status consisting either no deletion (n = 57) or co-deletion (n = 102), were used in our study. We quantified the imaging profile of these tumors by extracting diverse imaging features, including the tumor’s spatial distribution pattern, volumetric, texture, and intensity distribution measures. We integrated these diverse features via support vector machines, to construct an imaging signature of 1p/19q, which was evaluated in independent discovery (n = 85) and validation (n = 74) cohorts, and compared with the 1p/19q status obtained through fluorescence in-situ hybridization test. The classification accuracy on complete, discovery and replication cohorts was 86.16%, 88.24%, and 85.14%, respectively. The classification accuracy when the model developed on training cohort was applied on unseen replication set was 82.43%. Non-invasive prediction of 1p/19q status from MRIs would allow improved treatment planning for LGG patients without the need of surgical biopsies and would also help in potentially monitoring the dynamic mutation changes during the course of the treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Louis, D., et al.: World Health Organization classification of tumours of the central nervous system. In: International Agency for Research on Cancer, Lyon, p. 4 (2007)

    Google Scholar 

  2. Fellah, S., et al.: Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis? AJNR Am. J. Neuroradiol. 34, 1326–1333 (2013)

    Article  Google Scholar 

  3. Jansen, N.L., et al.: Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol. 14, 1473–1480 (2012)

    Article  Google Scholar 

  4. Iwadate, Y., et al.: Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. J. Neurol. Neurosurg. Psychiatry 87, 1016–1021 (2016)

    Article  Google Scholar 

  5. Bourdillon, P., et al.: Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status. J. Neurooncol. 122, 529–537 (2015)

    Article  Google Scholar 

  6. Akkus, Z., et al.: Predicting deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J. Digit. Imaging 30, 469–476 (2017)

    Article  Google Scholar 

  7. Zhou, H., et al.: MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol. 19, 862–870 (2017)

    Article  Google Scholar 

  8. Chaddad, A., et al.: Predicting the gene status and survival outcome of lower grade glioma patients with multimodal MRI features. IEEE Access 7, 75976–75984 (2019)

    Article  Google Scholar 

  9. Chang, C.C., Lin, C.J.: LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol. (TIST) 2, 27 (2011)

    Google Scholar 

  10. Rathore, S., et al.: Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Sci. Rep. 8, 5087 (2018)

    Article  Google Scholar 

  11. Rathore, S., et al.: A radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma: implications for personalized radiotherapy planning. J. Med. Imaging 5, 021219 (2018)

    Article  Google Scholar 

  12. Macyszyn, L., et al.: Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro Oncol. 18, 417–425 (2016)

    Article  Google Scholar 

  13. Rathore, S., et al.: Technical note: a radiomic signature of infiltration in peritumoral edema predicts subsequent recurrence in glioblastoma. In: Medical Imaging 2018: Image-Guided Procedures, Robotic Interventions, and Modeling, vol. 10576, p. 105760O (2018)

    Google Scholar 

  14. Shukla-Dave, A., et al.: The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int. 99, 786–793 (2007)

    Article  Google Scholar 

  15. Rathore, S., et al.: Multivariate pattern analysis of de novo glioblastoma patients offers in vivo evaluation of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status, compensating for insufficient specimen and assay failures. J. Neuro-oncol. 20, vi186 (2018)

    Google Scholar 

  16. Bakas, S., et al.: In vivo detection of EGFRvIII in glioblastoma via perfusion magnetic resonance imaging signature consistent with deep peritumoral infiltration: the phi-index. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 23, 4724–4734 (2017)

    Article  Google Scholar 

  17. Smith, S.M., Brady, J.M.: SUSAN - a new approach to low level image processing. Int. J. Comput. Vis. 23, 45–78 (1997)

    Article  Google Scholar 

  18. Tustison, N.J., et al.: N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310–1320 (2010)

    Article  Google Scholar 

  19. Jenkinson, M., Smith, S.: A global optimisation method for robust affine registration of brain images. Med. Image Anal. 5, 143–156 (2001)

    Article  Google Scholar 

  20. Smith, S.M.: Fast robust automated brain extraction. Hum. Brain Mapp. 17, 143–155 (2002)

    Article  Google Scholar 

  21. Yushkevich, P.A., et al.: User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 31, 1116–1128 (2006)

    Article  Google Scholar 

  22. Haralick, R.M., et al.: Textural features for image classification. IEEE Trans. Syst. Man Cybern. 3, 610–621 (1973)

    Article  Google Scholar 

  23. Galloway, M.M.: Texture analysis using grey level run lengths. Comput. Graph. Image Process. 4, 172–179 (1975)

    Article  Google Scholar 

  24. Bilello, M., et al.: Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma. Neuroimage Clin. 12, 34–40 (2016)

    Article  Google Scholar 

  25. Rathore, S., et al.: GECC: gene expression based ensemble classification of colon samples. IEEE/ACM Trans. Comput. Biol. Bioinf. 11, 1131–1145 (2014)

    Article  Google Scholar 

  26. Rathore, S., et al.: Automated colon cancer detection using hybrid of novel geometric features and some traditional features. Comput. Biol. Med. 65, 279–296 (2015)

    Article  Google Scholar 

  27. Sullivan, G.M., Feinn, R.: Using effect size-or why the P value is not enough. J. Grad. Med. Educ. 4, 279–282 (2012)

    Article  Google Scholar 

  28. Verhaak, R.G., et al.: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98–110 (2010)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saima Rathore .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Rathore, S., Chaddad, A., Bukhari, N.H., Niazi, T. (2020). Imaging Signature of 1p/19q Co-deletion Status Derived via Machine Learning in Lower Grade Glioma. In: Mohy-ud-Din, H., Rathore, S. (eds) Radiomics and Radiogenomics in Neuro-oncology. RNO-AI 2019. Lecture Notes in Computer Science(), vol 11991. Springer, Cham. https://doi.org/10.1007/978-3-030-40124-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40124-5_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-40123-8

  • Online ISBN: 978-3-030-40124-5

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics